Literature DB >> 29753761

Grand Rounds: Alcoholic Hepatitis.

Ashwani K Singal1, Alexandre Louvet2, Vijay H Shah3, Patrick S Kamath3.   

Abstract

A 33-year-old Caucasian male was admitted to hospital with recent onset of jaundice of 2-3 weeks duration. He reported heavy use of alcohol for the last 10 years with the last drink a day prior to the onset of symptoms. At admission, he was alert and oriented to time, place, and person, and was deeply jaundiced. His laboratory profile can be summarised as follows: haemoglobin 12.1 g/dl, white blood cell count 18,700 with 81% neutrophils, serum bilirubin 33 (direct 22) mg/dl, aspartate aminotransferase 147 IU/L, alanine aminotransferase 62 IU/L, alkaline phosphatase 117 IU/L, serum albumin 2.8 gm/dl, serum creatinine 0.6 mg/dl, prothrombin time 18.3 (control 14.5) seconds, and international normalized ratio 1.48. He was diagnosed with severe alcoholic hepatitis (Maddrey discriminant function score of 50) and treated with prednisolone for 28 days with symptomatic and biochemical improvement. His Lille score at seven days was 0.4, and his serum bilirubin had decreased to 3.5 mg/dl at the end of treatment. He was also seen by the addiction team during hospitalisation; he agreed to follow through on recommendations. He was dismissed after completing a three-week inpatient rehabilitation programme but relapsed to alcohol use three months later, and was readmitted with alcohol withdrawal. He was readmitted two months later (about six months from the first episode) for a second episode of severe alcoholic hepatitis. At admission, his model for end-stage liver disease score was 32 and he was treated again with corticosteroids. His Lille score at seven days was 0.6 and steroids were discontinued. The hospital course was complicated by spontaneous bacterial peritonitis and pneumonia with development of acute kidney injury. He continued to worsen, developing multiorgan failure. After a course of one month, the family's preference was for him to receive comfort measures. This scenario raises several questions.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Corticosteroids; Liver biopsy; Liver transplantation

Mesh:

Substances:

Year:  2018        PMID: 29753761      PMCID: PMC6258018          DOI: 10.1016/j.jhep.2018.05.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  81 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

Authors:  Thierry Gustot; Javier Fernandez; Elisabet Garcia; Filippo Morando; Paolo Caraceni; Carlo Alessandria; Wim Laleman; Jonel Trebicka; Laure Elkrief; Corinna Hopf; Pablo Solís-Munoz; Faouzi Saliba; Stefan Zeuzem; Augustin Albillos; Daniel Benten; José Luis Montero-Alvarez; Maria Teresa Chivas; Mar Concepción; Juan Córdoba; Aiden McCormick; Rudolf Stauber; Wolfgang Vogel; Andrea de Gottardi; Tania M Welzel; Marco Domenicali; Alessandro Risso; Julia Wendon; Carme Deulofeu; Paolo Angeli; François Durand; Marco Pavesi; Alexander Gerbes; Rajiv Jalan; Richard Moreau; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

Review 3.  Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.

Authors:  Craig McClain; Shirish Barve; Swati Joshi-Barve; Zhenyuan Song; Ion Deaciuc; Theresa Chen; Daniell Hill
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

4.  A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.

Authors:  Julien Bissonnette; José Altamirano; Cécile Devue; Olivier Roux; Audrey Payancé; Didier Lebrec; Pierre Bedossa; Dominique Valla; François Durand; Hafid Ait-Oufella; Pau Sancho-Bru; Joan Caballeria; Pere Ginès; Chantal M Boulanger; Ramon Bataller; Pierre-Emmanuel Rautou
Journal:  Hepatology       Date:  2017-06-22       Impact factor: 17.425

5.  Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.

Authors:  Alexandre Louvet; Julien Labreuche; Florent Artru; Alexis Bouthors; Benjamin Rolland; Pierre Saffers; Julien Lollivier; Elise Lemaître; Sébastien Dharancy; Guillaume Lassailly; Valérie Canva-Delcambre; Alain Duhamel; Philippe Mathurin
Journal:  Hepatology       Date:  2017-09-26       Impact factor: 17.425

Review 6.  Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2016-03-04       Impact factor: 22.682

7.  Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians.

Authors:  Ashwani K Singal; Habeeb Salameh; Anjna Singal; Sarat C Jampana; Daniel H Freeman; Karl E Anderson; Don Brunder
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-05-06

8.  Prednisolone or pentoxifylline for alcoholic hepatitis.

Authors:  Mark R Thursz; Paul Richardson; Michael Allison; Andrew Austin; Megan Bowers; Christopher P Day; Nichola Downs; Dermot Gleeson; Alastair MacGilchrist; Allister Grant; Steven Hood; Steven Masson; Anne McCune; Jane Mellor; John O'Grady; David Patch; Ian Ratcliffe; Paul Roderick; Louise Stanton; Nikhil Vergis; Mark Wright; Stephen Ryder; Ewan H Forrest
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245

9.  White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers.

Authors:  Timothy Hardy; Christopher Wells; Stuart Kendrick; Mark Hudson; Christopher P Day; Alastair D Burt; Steven Masson; Stephen F Stewart
Journal:  BMC Gastroenterol       Date:  2013-03-26       Impact factor: 3.067

Review 10.  The Bioenergetic Health Index: a new concept in mitochondrial translational research.

Authors:  Balu K Chacko; Philip A Kramer; Saranya Ravi; Gloria A Benavides; Tanecia Mitchell; Brian P Dranka; David Ferrick; Ashwani K Singal; Scott W Ballinger; Shannon M Bailey; Robert W Hardy; Jianhua Zhang; Degui Zhi; Victor M Darley-Usmar
Journal:  Clin Sci (Lond)       Date:  2014-09       Impact factor: 6.124

View more
  17 in total

1.  An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.

Authors:  Juan P Arab; Tejasav S Sehrawat; Douglas A Simonetto; Vikas K Verma; Dechun Feng; Tom Tang; Kevin Dreyer; Xiaoqiang Yan; William L Daley; Arun Sanyal; Naga Chalasani; Svetlana Radaeva; Liu Yang; Hugo Vargas; Mauricio Ibacache; Bin Gao; Gregory J Gores; Harmeet Malhi; Patrick S Kamath; Vijay H Shah
Journal:  Hepatology       Date:  2020-04-27       Impact factor: 17.425

Review 2.  Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  Transl Gastroenterol Hepatol       Date:  2019-10-11

3.  Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis.

Authors:  Archana Rastogi; Nayana Patil; Rakhi Maiwall; Chhagan Bihari; Ananda Soshee; Shiv K Sarin
Journal:  Virchows Arch       Date:  2021-04-02       Impact factor: 4.064

4.  Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis-Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care.

Authors:  Cyriac A Philips; Rizwan Ahamed; Sasidharan Rajesh; Jinsha K P Abduljaleel; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2022-01-08

Review 5.  Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure.

Authors:  Loretta Jophlin; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2021-08-14

6.  Epidemiological profile of alcoholic liver disease hospital admissions in a Latin American country over a 10-year period.

Authors:  Andre Castro Lyra; Lorena Mascarenhas Carneiro de Almeida; Yukari Figueroa Mise; Lourianne Nascimento Cavalcante
Journal:  World J Hepatol       Date:  2020-05-27

7.  Barriers for Liver Transplant in Patients with Alcohol-Related Hepatitis.

Authors:  Gina Choi; Jihane N Benhammou; Jung J Yum; Elena G Saab; Ankur P Patel; Andrew J Baird; Stephanie Aguirre; Douglas G Farmer; Sammy Saab
Journal:  J Clin Exp Hepatol       Date:  2021-09-22

8.  Gut Microbiota in Alcoholic Hepatitis is Disparate from Those in Acute Alcoholic Pancreatitis and Biliary Disease.

Authors:  Cyriac A Philips; Nikhil Phadke; Karthik Ganesan; Sasidharan Rajesh; Guruprasad Padsalgi; Rizwan Ahamed; Solomon K John; Gopakumar C Valiathan; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2019-04-14

9.  Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.

Authors:  Tejasav S Sehrawat; Juan P Arab; Mengfei Liu; Pouya Amrollahi; Meihua Wan; Jia Fan; Yasuhiko Nakao; Elisa Pose; Amaia Navarro-Corcuera; Debanjali Dasgupta; Chieh-Yu Liao; Li He; Amy S Mauer; Emma Avitabile; Meritxell Ventura-Cots; Ramon A Bataller; Arun J Sanyal; Naga P Chalasani; Julie K Heimbach; Kymberly D Watt; Gregory J Gores; Pere Gines; Patrick S Kamath; Douglas A Simonetto; Tony Y Hu; Vijay H Shah; Harmeet Malhi
Journal:  Hepatology       Date:  2020-10-30       Impact factor: 17.425

10.  Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis.

Authors:  Camelia Gianina Foncea; Ioan Sporea; Raluca Lupușoru; Tudor Voicu Moga; Felix Bende; Roxana Șirli; Alina Popescu
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.